These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 6323979

  • 1. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
    Rahn KH, Stumpe KO.
    MMW Munch Med Wochenschr; 1984 Feb 22; 126 Suppl 1():S5-14. PubMed ID: 6323979
    [No Abstract] [Full Text] [Related]

  • 2. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK, Vlasses PH, Riley LJ.
    Ration Drug Ther; 1984 Mar 22; 18(3):1-5. PubMed ID: 6093192
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA, de Bruyn JH, Wenting GJ, Man in 't Veld AJ, Derkx FH.
    Ned Tijdschr Geneeskd; 1980 Nov 22; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Current aspects of the clinical effectiveness and tolerance of captopril in the treatment of cardiovascular diseases].
    Ol'binskaia LI, Mokhova OV.
    Ter Arkh; 1984 Nov 22; 56(11):139-42. PubMed ID: 6395426
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G, Melina D.
    Minerva Cardioangiol; 1983 Mar 22; 31(3):101-6. PubMed ID: 6304570
    [No Abstract] [Full Text] [Related]

  • 14. Captopril: an oral angiotension converting enzyme inhibitor active in man.
    Brunner HR, Gavras H, Waeber B, Turini GA, Wauters JP.
    Arch Int Pharmacodyn Ther; 1980 Mar 22; Suppl():188-212. PubMed ID: 6251762
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of chronic refractory cardiac insufficiency with an inhibitor of converting enzyme. Long-term results].
    Charbonnier B, Monpère C, Desveaux B, Cosnay P, Fauchier JP, Brochier M.
    Ann Cardiol Angeiol (Paris); 1984 Mar 22; 33(4):233-7. PubMed ID: 6087714
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 22; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 20. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
    Morimoto Y, Baba M, Takahashi T, Fujii M, Konishi T, Kawanami C, Hamada M, Nakano T, Takezawa H.
    Kokyu To Junkan; 1982 Mar 22; 30(3):317-25. PubMed ID: 6808624
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.